Hemogenyx Pharmaceuticals Plc sell dimontalban
Start price
18.09.25
/
70%
€17.90
Target price
18.09.26
€1.00
Performance (%)
-31.28%
End price
28.09.25
€12.30
Summary
This prediction ended on 28.09.25 with a price of €12.30. dimontalban correctly predicted massive losses of -31.28% for Hemogenyx Pharmaceuticals Plc. dimontalban has 70% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Hemogenyx Pharmaceuticals Plc | - | - |
| iShares Core DAX® | 0.734% | -0.964% |
| iShares Nasdaq 100 | -2.686% | -2.409% |
| iShares Nikkei 225® | -2.261% | -4.038% |
| iShares S&P 500 | -1.346% | -1.510% |
According to dimontalban what are the pros and cons of Hemogenyx Pharmaceuticals Plc for the foreseeable future?
Pros
Capable Management
Sustainability is important
Small cyclical dependencies
Future proof or reliable business model
Cons
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline > 20% expected
Lower EBIT Margin than peer group
overvalued
Very low/no dividend yield expected
very negative Cash Flow expected
Bad rating
Little Investments for future growth
High risks in the balance sheet
ROE lower than 10% per year
High challenges to pay loans and raise capital
Bad culture
Little innovation
Few uniques
Dependend from few customers or products
Growths slower than the competition
high free float
High risks for its business
Below average Marketposition
Little known brand
Comments by dimontalban for this prediction
In the thread Hemogenyx Pharmaceuticals Plc diskutieren
Sell mit Kursziel 1,0